耳用抗感染
Otitis media, acute: Treatment of acute otitis media with tympanostomy tubes due to susceptible isolates of S. aureus, S. pneumoniae, H. influenzae, Moraxella catarrhalis, and P. aeruginosa in pediatric patients 1 year and older.
Otitis media, chronic suppurative: Treatment of chronic supportive otitis media with perforated tympanic membranes due to susceptible isolates of Proteus mirabilis, P. aeruginosa, and S. aureus in patients 12 years and older.
Otitis externa: Treatment of otitis externa due to susceptible isolates of E. coli, P. aeruginosa, and S. aureus in adults and pediatric patients 6 months and older.

Fluoroquinolone anti-infective agent

Absorption: Only small amounts are absorbed systemically after otic instillation

1. Hypersensitivity to ofloxacin or to other fluoroquinolones
2. Otic solution is not for ophthalmic use or for injection

The amount of ofloxacin available systemically following topical application of the otic drops is significantly less in comparison to oral doses.

Due to the potential for serious adverse reactions in the nursing infant, the manufacturer recommends a decision be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother.

Hypersensitivity, ear pain, replacement the rehabitated external normal flora

otitis externa 5 to 10 drops twice a day for 10 days

1-12 years of age: 5 drops twice a day for 10 days